VA often failed to inform patients about risks of COVID antiviral drug

SHARE OF THE DAY

VA often failed to inform patients about risks of COVID antiviral drug
By Irene Loewenson
Sep 6, 04:14 PM
The VA Office of Inspector General pointed to “significant deficiencies” in health care providers’ compliance with requirements to notify patients and caregivers about the risks associated with the COVID-19 antiviral drug remdesivir. (Dirk Waem/Belga/AFP via Getty Images)

Health care providers in Veterans Health Administration facilities often failed to fully inform patients and caregivers about the risks of the COVID antiviral remdesivir in the months before the drug was approved by the Food and Drug Administration, according to a report Thursday by the Veterans Affairs watchdog.

PO1 William "Chip" Nagel Lt Col Charlie Brown SSG Michael Noll Lt Col John (Jack) Christensen Cpl Vic Burk SGT (Join to see) SGT David A. 'Cowboy' Groth ] Sgt (Join to see) SPC Michael Terrell CPL Douglas Chrysler A1C Medrick "Rick" DeVaney GySgt Jack Wallace SGT Mark Anderson CPL LaForest Gray SFC David Reid, M.S, PHR, SHRM-CP, DTM PV2 Larry Sellnow MSG Darold R. PO2 Marco Monsalve SGT Steve McFarland SrA John Monette